J2360 HCPCS code: Injection, orphenadrine citrate, up to 60 mg
J2360 is the HCPCS Level II code for injection, orphenadrine citrate, up to 60 mg. In 2024 Medicare paid an average of $6.29 per service for J2360 across 5,782 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume fell 50% from 2022 to 2024 (11,641 to 5,782 services). In 2024, about 1,235 clinicians billed Medicare for J2360 for 3,619 beneficiaries; Florida, Alabama, Mississippi accounted for 44% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J2360 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,235 |
| Medicare beneficiaries | 3,619 |
| States with claims | 35 |
| Share of services in top 3 states (Florida, Alabama, Mississippi) | 44% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2360, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 11,641 | 6,230 | $4.36 | $3.17 |
| 2023 | 7,306 | 4,629 | $6.43 | $4.75 |
| 2024 | 5,782 | 3,619 | $8.74 | $6.29 |
States with the most J2360 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,241 | $6.81 |
| Alabama | 893 | $5.94 |
| Mississippi | 374 | $6.40 |
| Texas | 349 | $6.03 |
| California | 342 | $6.57 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | Prescribing Information |
| practitioner claims | 2 | Prescribing Information |
What changed for J2360
- 1982-01-01: J2360 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2360?
J2360 is the HCPCS Level II code for injection, orphenadrine citrate, up to 60 mg. Short descriptor: "Orphenadrine injection".
How much does Medicare pay for J2360?
In 2024, the average Medicare payment was $6.29 per service (average allowed $8.74).
Does Medicare cover J2360?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J2360 can be billed per day?
3 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2305 — Injection, nitroglycerin, 5 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2360
- Watch J2360 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2360
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.